242 related articles for article (PubMed ID: 19628366)
1. Venous thromboembolism prophylaxis after major orthopaedic surgery: a pooled analysis of randomized controlled trials.
Brown GA
J Arthroplasty; 2009 Sep; 24(6 Suppl):77-83. PubMed ID: 19628366
[TBL] [Abstract][Full Text] [Related]
2. Aspirin for the prophylaxis of venous thromboembolic events in orthopedic surgery patients: a comparison of the AAOS and ACCP guidelines with review of the evidence.
Stewart DW; Freshour JE
Ann Pharmacother; 2013 Jan; 47(1):63-74. PubMed ID: 23324504
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
[TBL] [Abstract][Full Text] [Related]
4. Long-term use of different doses of low-molecular-weight heparin versus vitamin K antagonists in the treatment of venous thromboembolism.
Romera-Villegas A; Cairols-Castellote MA; Vila-Coll R; Martí-Mestre X; Colomé E; Iguaz I
Ann Vasc Surg; 2010 Jul; 24(5):628-39. PubMed ID: 19932949
[TBL] [Abstract][Full Text] [Related]
5. Current strategies in prophylaxis and treatment of venous thromboembolism.
Schulman S
Ann Med; 2008; 40(5):352-9. PubMed ID: 18484347
[TBL] [Abstract][Full Text] [Related]
6. Thromboprophylaxis in orthopedic surgery: how long is long enough?
Muntz J
Am J Orthop (Belle Mead NJ); 2009 Aug; 38(8):394-401. PubMed ID: 19809604
[TBL] [Abstract][Full Text] [Related]
7. Aspirin and compression devices versus low-molecular-weight heparin and PCD for VTE prophylaxis in orthopedic oncology patients.
Patel AR; Crist MK; Nemitz J; Mayerson JL
J Surg Oncol; 2010 Sep; 102(3):276-81. PubMed ID: 20740587
[TBL] [Abstract][Full Text] [Related]
8. [Advancement of prophylaxis and therapy for venous thromboembolism].
Kobayashi T
Rinsho Byori; 2008 Jul; 56(7):589-99. PubMed ID: 18709991
[TBL] [Abstract][Full Text] [Related]
9. Prevention of deep vein thrombosis in cancer patients.
Lee AY
Semin Thromb Hemost; 2007 Oct; 33(7):699-706. PubMed ID: 18000798
[TBL] [Abstract][Full Text] [Related]
10. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
Huo MH; Muntz J
Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of anticoagulant prophylaxis to prevent venous thromboembolism in acutely ill medical inpatients: a meta-analysis.
Själander A; Jansson JH; Bergqvist D; Eriksson H; Carlberg B; Svensson P
J Intern Med; 2008 Jan; 263(1):52-60. PubMed ID: 18088252
[TBL] [Abstract][Full Text] [Related]
12. Assessing the quality of pharmacological treatments from administrative databases: the case of low-molecular-weight heparin after major orthopaedic surgery.
Gerkens S; Beguin C; Crott R; Closon MC; Horsmans Y
J Eval Clin Pract; 2008 Aug; 14(4):585-94. PubMed ID: 18462276
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy and safety of aspirin in prevention of venous thromboembolism after total joint arthroplasty].
Tian H; Song F; Zhang K; Liu Y
Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(47):3349-52. PubMed ID: 18478950
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of extended thrombo-prophylaxis in major abdominal surgery: what does the evidence show? A meta-analysis.
Bottaro FJ; Elizondo MC; Doti C; Bruetman JE; Perez Moreno PD; Bullorsky EO; Ceresetto JM
Thromb Haemost; 2008 Jun; 99(6):1104-11. PubMed ID: 18521515
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the effectiveness and safety of bemiparin in a large population of orthopedic patients in a normal clinical practice.
Otero-Fernández R; Gómez-Outes A; Martínez-González J; Rocha E; Fontcuberta J;
Clin Appl Thromb Hemost; 2008 Jan; 14(1):75-83. PubMed ID: 17895506
[TBL] [Abstract][Full Text] [Related]
16. Prevention of venous thromboembolism in hospitalized medical patients.
Lenchus JD; Jaffer AK
Mt Sinai J Med; 2008 Oct; 75(5):449-53. PubMed ID: 18828167
[TBL] [Abstract][Full Text] [Related]
17. Unanswered questions in venous thromboembolism.
Weitz JI
Thromb Res; 2009; 123 Suppl 4():S2-S10. PubMed ID: 19303498
[TBL] [Abstract][Full Text] [Related]
18. [Venous thromboembolism prophylaxis in internal medicine].
Malý J; Widimský J; Dulícek P
Vnitr Lek; 2009 Mar; 55(3):190-5. PubMed ID: 19378845
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the duration of thromboembolic prophylaxis after high-risk orthopaedic surgery: the ETHOS observational study.
Bergqvist D; Arcelus JI; Felicissimo P;
Thromb Haemost; 2012 Feb; 107(2):270-9. PubMed ID: 22186708
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of prolonged thromboprophylaxis after cancer surgery.
Bradley CT; Brasel KJ; Miller JJ; Pappas SG
Ann Surg Oncol; 2010 Jan; 17(1):31-9. PubMed ID: 19707830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
